/PRNewswire/ AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today provided an update on the Company s share repurchase program (the "Share.
/PRNewswire/ AIkido Pharma Inc. (NASDAQ: AIKI) ("AIkido" or the "Company") today provided an update on the $3 million share repurchase program (the "Share.
/PRNewswire/ AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today confirms that on August 9, 2022, the Company received an unsolicited offer.
/PRNewswire/ AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") announced the formation of a wholly owned subsidiary with the purpose of making.
/PRNewswire/ AIkido Pharma, Inc. (NASDAQ:AIKI), today announced that the Company s Board of Directors has approved a reverse stock split of its shares of.